MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.

Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer with significantly high prevalence in Southern China. Unlike other head and neck cancers, mutations or deletions of tumor suppressor genes in NPC are not common. Recently, downregulation of tumor suppressor genes expression by microRNA (miRNA) is increasingly recognized as an important mechanism of nasopharyngeal tumorigenesis. In this study, we reported that microRNA-144 (miR-144) was frequently upregulated in NPC specimens and cell lines. Repression of miR-144 significantly decreased cell proliferation, clonogenicity, migration, invasion and tumor formation in nude mice, while restoring miR-144 in miR-144-attenuated NPC cells exhibited a strong tumorigenic role. Further, we found that miR-144 was inversely correlated with the tumor suppressor gene phosphatase and tensin homolog (PTEN) in NPC specimens and cell lines, and then we identified PTEN as a direct target of miR-144 in NPC cell lines. PTEN downregulation in miR-144-attenuated cells could increase cell growth, migration and invasion. Mechanistic investigations revealed that miR-144 suppressed the expression of PTEN to increase the expression of pAkt and cyclin D1 to promote G(1)-phase transition and decrease E-cadherin to promote migration and invasion. Taken together, we provide compelling evidence that miR-144 functions as an onco-miRNA in NPC, and its oncoeffects are mediated chiefly by repressing PTEN expression to activate the PI3K/Akt pathway.

[1]  D. Kwong,et al.  Profiling of Epstein‐Barr virus‐encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs , 2012, Cancer.

[2]  Jing Zhao,et al.  Human tumor microRNA signatures derived from large‐scale oligonucleotide microarray datasets , 2011, International journal of cancer.

[3]  P. Pantazis,et al.  Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism , 2011, Journal of nanobiotechnology.

[4]  M. Telen,et al.  microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease. , 2010, Blood.

[5]  Yaou Zhang,et al.  Expression of Versican 3′-Untranslated Region Modulates Endogenous MicroRNA Functions , 2010, PloS one.

[6]  J Ma,et al.  MicroRNA and drug resistance , 2010, Cancer Gene Therapy.

[7]  M. Loda,et al.  Identification of the miR-106b~25 MicroRNA Cluster as a Proto-Oncogenic PTEN-Targeting Intron That Cooperates with Its Host Gene MCM7 in Transformation , 2010, Science Signaling.

[8]  M. Zhou,et al.  microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. , 2010, Carcinogenesis.

[9]  P. Deloukas,et al.  Signatures of mutation and selection in the cancer genome , 2010, Nature.

[10]  Wenlin Huang,et al.  The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. , 2009, The Journal of clinical investigation.

[11]  G. Calin,et al.  An Integrated Approach for Experimental Target Identification of Hypoxia-induced miR-210* , 2009, The Journal of Biological Chemistry.

[12]  C. Croce.  Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[13]  Bo Wang,et al.  Role of microRNA‐155 at early stages of hepatocarcinogenesis induced by choline‐deficient and amino acid–defined diet in C57BL/6 mice , 2009, Hepatology.

[14]  J. Waldron,et al.  Significance of Plk1 regulation by miR‐100 in human nasopharyngeal cancer , 2009, International journal of cancer.

[15]  S. D. Selcuklu,et al.  miR-21 as a key regulator of oncogenic processes. , 2009, Biochemical Society transactions.

[16]  Reuven Agami,et al.  The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. , 2009, Genes & development.

[17]  Mina J Bissell,et al.  Interaction of E-cadherin and PTEN regulates morphogenesis and growth arrest in human mammary epithelial cells. , 2009, Cancer research.

[18]  George A. Calin,et al.  MicroRNAs — the micro steering wheel of tumour metastases , 2009, Nature Reviews Cancer.

[19]  H. Baba,et al.  MicroRNA-21 Regulates the Proliferation and Invasion in Esophageal Squamous Cell Carcinoma , 2009, Clinical Cancer Research.

[20]  S. Baker,et al.  PTEN and the PI3-kinase pathway in cancer. , 2009, Annual review of pathology.

[21]  Saijuan Chen,et al.  Mir-144 selectively regulates embryonic alpha-hemoglobin synthesis during primitive erythropoiesis. , 2009, Blood.

[22]  D. Kwong,et al.  An Epstein-Barr virus–encoded microRNA targets PUMA to promote host cell survival , 2008, The Journal of experimental medicine.

[23]  Anna M. Krichevsky,et al.  miR-21: a small multi-faceted RNA , 2008, Journal of cellular and molecular medicine.

[24]  Pier Paolo Pandolfi,et al.  Tenets of PTEN Tumor Suppression , 2008, Cell.

[25]  Paul Ahlquist,et al.  MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins , 2008, Proceedings of the National Academy of Sciences.

[26]  Xiaowu Gai,et al.  A GATA-1-regulated microRNA locus essential for erythropoiesis , 2008, Proceedings of the National Academy of Sciences.

[27]  Huan Yang,et al.  MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. , 2008, Cancer research.

[28]  Charles D. Johnson,et al.  Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. , 2007, Cancer research.

[29]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.

[30]  Q. Tao,et al.  Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments , 2007, Expert Reviews in Molecular Medicine.

[31]  P. Meltzer,et al.  Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase , 2006, International journal of cancer.

[32]  H. Dralle,et al.  CpG island methylation of tumor-related promoters occurs preferentially in undifferentiated carcinoma. , 2006, Thyroid : official journal of the American Thyroid Association.

[33]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[34]  Xiaoqiu Chen,et al.  [The relationship between hypermethylation of the PTEN promoter and laryngeal squamous cell carcinoma]. , 2006, Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology.

[35]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[36]  Cristina M. Pinto,et al.  Retracted: Frequent genetic and biochemical alterations of the PI 3‐K/AKT/PTEN pathway in head and neck squamous cell carcinoma , 2005, International journal of cancer.

[37]  M. Byrom,et al.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.

[38]  X. Huo,et al.  [Expression and significance of PTEN in nasopharyngeal carcinoma]. , 2004, Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology.

[39]  Kwok Wai Lo,et al.  Focus on nasopharyngeal carcinoma. , 2004, Cancer cell.

[40]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[41]  J. Watkinson,et al.  The aetiology of nasopharyngeal carcinoma. , 2001, Clinical otolaryngology and allied sciences.

[42]  S. Cheung,et al.  Nasopharyngeal carcinoma cell line (C666‐1) consistently harbouring Epstein‐Barr virus , 1999, International journal of cancer.

[43]  Chi-Hung Lin,et al.  Chromosomal aberrations in nasopharyngeal carcinoma analyzed by comparative genomic hybridization , 1999, Genes, chromosomes & cancer.

[44]  S. Cheung,et al.  Characterization of a new EBV-associated nasopharyngeal carcinoma cell line. , 1998, Cancer genetics and cytogenetics.

[45]  W. K. Alfred Yung,et al.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.

[46]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[47]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[48]  Z. Sizhong,et al.  Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma , 1983, International journal of cancer.

[49]  S. Chan.  Aetiology of Nasopharyngeal Carcinoma , 1976, The Lancet.

[50]  X. Bian,et al.  miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. , 2010, Biochemical and biophysical research communications.

[51]  Q. Chen,et al.  Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma. , 2000, Oral oncology.